Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, IDEXX Laboratories (Nasdaq: IDXX) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at IDEXX's business and see what CAPS investors are saying about the stock right now.

IDEXX facts

Headquarters (founded) Westbrook, Maine (1983)
Market Cap $5.1 billion
Industry Health care equipment
Trailing-12-Month Revenue $1.3 billion
Management Chairman/CEO Jonathan Ayers
CFO Merilee Raines
Return on Equity (average, past 3 years) 27.5%
Cash/Debt $201.8 million / $247.0 million
Competitors Abaxis
VCA Antech

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 95% of the 236 members who have rated IDEXX believe the stock will outperform the S&P 500 going forward.

Just last month, one of those Fools, TMFJLo, succinctly summed up the bull case for our community:

A bit expensive, but IDEXX is a technology healthcare leader not only for animals, but also for humans. Cloud computing that connects diagnostics labs to clinics = exceptional idea. No competitors to speak of and aggressive recruiting incentives (free software). 5 straight quarters of beating expectations doesn't hurt, either.  

If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, IDEXX may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.